News Releases

Date	Title
05/12/21	MIMEDX Reminds Shareholders to Vote at the Upcoming Annual Meeting
05/10/21	MIMEDX to Participate at Upcoming Investor Conferences
05/06/21	MIMEDX Announces Collaborative Agreement with the Wake Forest Institute for Regenerative Medicine
05/04/21	MIMEDX Urges Shareholders to Consider Prescience Point’s Motivations Before Voting Their Shares at the Company’s Annual Meeting
05/03/21	MIMEDX Files Definitive Proxy Materials and Mails Letter to Shareholders Highlighting Actions Taken to Transform MIMEDX and Drive Significant Value for Shareholders
04/28/21	MiMedx Announces First Quarter 2021 Financial and Operating Results
04/28/21	MiMedx Welcomes Dirk Stevens, Ph.D., as Senior Vice President, Quality Assurance and Regulatory Affairs
04/22/21	MiMedx to Host First Quarter 2021 Operating and Financial Results Conference Call on April 29
04/19/21	MiMedx Announces Last Patients Last Visits in Three Late-Stage Musculoskeletal Trials with Proprietary Tissue Technology
04/16/21	MiMedx Confirms Receipt of Director Nominations from Prescience Point Capital Management